<DOC>
	<DOCNO>NCT02178969</DOCNO>
	<brief_summary>The purpose study well understand disease extent identify appropriate methodology evaluate ( dystrophic epidermolysis bullosa ) DEB quantitative qualitative manner .</brief_summary>
	<brief_title>Short Term Observational Study DEB Patients</brief_title>
	<detailed_description />
	<mesh_term>Epidermolysis Bullosa</mesh_term>
	<mesh_term>Epidermolysis Bullosa Dystrophica</mesh_term>
	<criteria>1 . Written inform consent provide . Patients 18 year age older , parent ( ) /legal guardian ( ) patient young 18 year age , must provide write informed consent prior participate study ; additionally , inform assent obtain patient young 18 year age specify local requirement . 2 . Patient must document diagnosis DEB base genetic analysis show mutation COL7A1 , opinion investigator , confirm diagnosis DEB base histologic criterion ( antigen map electron microscopy ) . 3 . Patient must least 5 wound suitable imaging , opinion investigator , time enrollment . 4 . Patient willing able undergo protocolspecified procedure . 1 . Patient use currently use experimental treatment DEB include , limited , bone marrow transplantation , systemic immune suppression , experimental procedure involve live cell , potential systemic spread gene transfer , stem cell infusion , cell type injection , opinion investigator , inclusion pose unacceptable risk patient interpretation study data . 2 . Patient squamous cell carcinoma evidence locally invasive disease distant metastasis . 3 . Patient pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>